Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TERRENCE A BOYADJIS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1669699120
CMS profile
667280
Location
WEST CHESTER, PA

General Payments · PY2018–2024

$2,652.58

  • Reported across 94 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$415.47

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $415.47 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Neurocrine BioSciences, Inc. $190.26 4
ITI, Inc. $147.98 7
Axsome Therapeutics, Inc. $77.23 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $479.99 14
PY2019 $263.11 10
PY2020 $646.32 21
PY2021 $529.87 24
PY2022 $67.28 4
PY2023 $250.54 7
PY2024 $415.47 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Axsome Therapeutics, Inc. $28.89 06/27/2024 Food and Beverage Undisputed 01/23/2026 1148324403 CMS
Axsome Therapeutics, Inc. $33.61 09/24/2024 Food and Beverage Undisputed 01/23/2026 1148324405 CMS
Axsome Therapeutics, Inc. $14.73 11/26/2024 Food and Beverage Undisputed 01/23/2026 1148324407 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.05 02/09/2024 Food and Beverage Undisputed 01/23/2026 1143197630 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.26 04/12/2024 Food and Beverage Undisputed 01/23/2026 1143197634 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.70 06/06/2024 Food and Beverage Undisputed 01/23/2026 1143197637 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.73 06/21/2024 Food and Beverage Undisputed 01/23/2026 1143197641 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.68 07/03/2024 Food and Beverage Undisputed 01/23/2026 1143197645 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2.74 07/29/2024 Food and Beverage Undisputed 01/23/2026 1143197648 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $34.82 10/24/2024 Food and Beverage Undisputed 01/23/2026 1143197652 CMS
Neurocrine Biosciences, Inc. $29.27 09/05/2024 Food and Beverage Undisputed 01/23/2026 1150827524 CMS
Neurocrine Biosciences, Inc. $19.96 11/04/2024 Food and Beverage Undisputed 01/23/2026 1150859159 CMS
Neurocrine Biosciences, Inc. $129.90 12/04/2024 Food and Beverage Undisputed 01/23/2026 1150808344 CMS
Neurocrine Biosciences, Inc. $11.13 12/14/2024 Food and Beverage Undisputed 01/23/2026 1150881635 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.